Summary

This individual maintains diverse professional affiliations across academia and industry. Roles include serving on SABs for various pharmaceutical and biotech firms, alongside academic posts such as Honorary Professor at UCL and Adjunct Professor at Trinity College Dublin, while also keeping ties with Brigham Women's Hospital and Harvard Medical School.

Recent developments highlight significant corporate activity and technological advancement. Aerska has announced several board appointments, signaling strategic strengthening, and has also reported a major $39M Series A funding round to advance its focus on delivering RNA medicines directly to the brain.

Title

Aerska | RNA medicines for diseases of the brain

Description

Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.

Keywords

therapeutics, development, former, university, senior, close, delivery, director, head, medicines, brain, research, scientist, experience, board, discovery, drug

Downstreams

globenewswire.com, personio.com, statnews.com, nobelprize.org, neurologylive.com, independent.ie, linkedin.com

NS Lookup

A 198.202.211.1

Dates

Created 2026-09-20

Updated 2026-09-28

Summarized 2026-09-28